A powerful committee of the freshly inaugurated Democrat-led US House of Representatives has launched a far-ranging investigation into the drug pricing practice 15 January 2019
A former chief executive of US specialty pharma firm Insys Therapeutics has entered a guilty plea to allegations of conspiring to bribe physicians to prescribe 10 January 2019
Madrid-based PharmaMar has launched a legal action against the European Commission to try to secure European Medicines Agency (EMA) approval for Aplidin (plitid 10 January 2019
Imogen Ireland, life sciences IP associate for law firm Hogan Lovells, raises some important issues relating to advances in artificial intelligence (AI) that dr 9 January 2019
The latest companies to breach the Association of the British Pharmaceutical Industry (ABPI) code of practice have been named and shamed. 17 December 2018
The US Patent and Trademark Appeal Board (PTAB) has ruled in favor of Netherlands-based drugmaker Mylan (Nasdaq) as it invalidated Sanofi’s Lantus (insulin glar 14 December 2018
The US House of Representatives has approved a bill that would prevent drugmakers from overcharging Medicaid in the way Mylan (Nasdaq: MYL) was famously accuse 12 December 2018
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.